NCT07671599 Perioperative Use of Continuous Glucose Monitoring for Scheduled Cesarean Deliveries (PERUSE)
| NCT ID | NCT07671599 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Dysglycemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-11-06 |
| Primary Completion | 2028-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2026-11-06 with a primary completion date of 2028-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective pilot study is exploratory in nature and is designed to evaluate the validity of continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients. Primary objective is characterization of perioperative glucose trends during elective Cesarean delivery in patients without diabetes and exploratory analyses will describe perioperative glucose patterns captured by CGM. Secondary objective is to examine rates of and associations with post-operative complications, including surgical site infections.
Eligibility Criteria
Inclusion Criteria: * singleton pregnancy * no prior diagnosis of diabetes (gestational included) * scheduled term cesarean delivery in Mount Sinai Health System * aged 18-50 years Exclusion Criteria: * preexisting diabetes mellitus * diagnosis of gestational diabetes mellitus (GDM) in the current pregnancy, based on standard prenatal screening * known endocrine disorder affecting glucose metabolism (such as Cushing syndrome, poorly controlled thyroid disorder, etc.) * use of antenatal steroids within the two weeks prior to delivery
Contact & Investigator
Angela Bianco, MD
PRINCIPAL INVESTIGATOR
Faculty
Frequently Asked Questions
Who can join the NCT07671599 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Dysglycemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07671599 currently recruiting?
Yes, NCT07671599 is actively recruiting participants. Contact the research team at nicola.tavella@mssm.edu for enrollment information.
Where is the NCT07671599 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07671599 clinical trial?
NCT07671599 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Angela Bianco, MD at Faculty. The trial plans to enroll 150 participants.